APOA1 and atherosclerosis: While only partially investigated in the setting of vascular interventions, the apoA1 gene transfer with helper-dependent adenoviral vectors27,28, and AAV vectors29,30 showed much promise for the slowing development of atherosclerosis and even reversal of established atherosclerotic plaques in hypercholesterolemic animal models.